Logo image of LILM

LILIUM NV (LILM) Stock Fundamental Analysis

NASDAQ:LILM - Nasdaq - NL0015000F41 - Common Stock - Currency: USD

0.052  -0.03 (-36.97%)

After market: 0.0564 +0 (+8.46%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LILM. LILM was compared to 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of LILM have multiple concerns. LILM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LILM has reported negative net income.
In the past year LILM has reported a negative cash flow from operations.
LILM had negative earnings in each of the past 5 years.
In the past 5 years LILM always reported negative operating cash flow.
LILM Yearly Net Income VS EBIT VS OCF VS FCFLILM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -100M -200M -300M -400M

1.2 Ratios

LILM has a Return On Assets of -124.74%. This is amonst the worse of the industry: LILM underperforms 93.94% of its industry peers.
LILM has a Return On Equity of -1050.03%. This is amonst the worse of the industry: LILM underperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROIC N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LILM Yearly ROA, ROE, ROICLILM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800 -1K

1.3 Margins

LILM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LILM Yearly Profit, Operating, Gross MarginsLILM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200K -400K -600K -800K

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for LILM has been increased compared to 1 year ago.
Compared to 1 year ago, LILM has an improved debt to assets ratio.
LILM Yearly Shares OutstandingLILM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
LILM Yearly Total Debt VS Total AssetsLILM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -7.40, we must say that LILM is in the distress zone and has some risk of bankruptcy.
LILM has a Altman-Z score of -7.40. This is amonst the worse of the industry: LILM underperforms 90.91% of its industry peers.
LILM has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.22, LILM is in the better half of the industry, outperforming 74.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -7.4
ROIC/WACCN/A
WACCN/A
LILM Yearly LT Debt VS Equity VS FCFLILM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

LILM has a Current Ratio of 0.84. This is a bad value and indicates that LILM is not financially healthy enough and could expect problems in meeting its short term obligations.
LILM has a worse Current ratio (0.84) than 87.88% of its industry peers.
LILM has a Quick Ratio of 0.84. This is a bad value and indicates that LILM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.84, LILM is not doing good in the industry: 68.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
LILM Yearly Current Assets VS Current LiabilitesLILM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.14% over the past year.
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.80% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LILM Yearly Revenue VS EstimatesLILM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
LILM Yearly EPS VS EstimatesLILM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LILM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LILM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LILM Price Earnings VS Forward Price EarningsLILM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LILM Per share dataLILM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y9.58%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LILM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LILIUM NV

NASDAQ:LILM (11/5/2024, 8:00:02 PM)

After market: 0.0564 +0 (+8.46%)

0.052

-0.03 (-36.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)09-25 2024-09-25/bmo
Earnings (Next)12-27 2024-12-27/bmo
Inst Owners2.7%
Inst Owner Change-96.78%
Ins Owners0.06%
Ins Owner Change0%
Market Cap32.90M
Analysts76.36
Price Target1.64 (3053.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.77%
PT rev (3m)12.17%
EPS NQ rev (1m)11.54%
EPS NQ rev (3m)11.54%
EPS NY rev (1m)15.02%
EPS NY rev (3m)15.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 226.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z -7.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)208.53%
Cap/Depr(5y)208.96%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.61%
EBIT Next 3Y12.51%
EBIT Next 5Y24.34%
FCF growth 1Y2.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.96%
OCF growth 3YN/A
OCF growth 5YN/A